Roche Sales Hit by Lower Covid Test Demand
Wall Street Journal
Roche backed its outlook for the year despite posting lower first-quarter revenue of €15.3 billion, as the diagnostics division saw a sales decline of 28% due to significantly weaker demand for Covid-19 tests.